Post by Centre for Eye and Vision Research

𝐅𝐫𝐨𝐦 𝐂𝐄𝐕𝐑 𝐋𝐚𝐛 𝐭𝐨 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐭𝐚𝐠𝐞: Entoptica 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐨𝐧 𝐑𝐓𝐇𝐊’𝐬 𝐕𝐢𝐛𝐫𝐚𝐧𝐭 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠! Catch the full episode details on: https://lnkd.in/gsndsaTC From deep tech lab benches to global healthcare stages, turning world-class research into real-world patient impact takes a strong ecosystem! We're incredibly proud to see Taranjit Singh, CEVR Researcher and Co-Founder/CTO of Entoptica, featured on RTHK’s Vibrant Hong Kong alongside Silas C. , Associate Executive Director, HKTDC. Together, they discussed how HKTDC’s Start-up Express programme is helping home-grown medtech start-ups scale internationally. Spun off directly from CEVR, Entoptica is transforming vision screening with its flagship device, SLOPE: 🔹Quantum-Inspired Precision: Evaluates macular function at a cellular level using structured light entoptic patterns. 🔹Primary Care Access: Fast and intuitive, enabling high-precision screening in community care . "Eye health is often overlooked until vision loss sets in. By making early screening fast, accessible, and accurate, we can protect sight for communities everywhere." — Taranjit Singh Congratulations to the Entoptica team, and thank you to Hong Kong Trade Development Council and Radio Television Hong Kong (RTHK) for championing Hong Kong’s medtech pioneers! Catch the full episode details on RTHK's Vibrant Hong Kong. #CEVR #Entoptica #StartUpExpress #HKTDC #MedTech #EyeHealth #HealthTech #HongKongInnovation #InnoHK #DeepTech #RTHK

Video Content